Pages

▼
Wednesday, May 4, 2022

NN1845 (a glucose sensitive insulin) Starts A Second Phase-1 Clinical Trail

›
One approach to creating a "practical cure" for T1D is sometimes called "smart insulin", "glucose sensitive insulin...
Tuesday, April 5, 2022

ViaCyte and CRISPR start a Phase-I Clinical Trial (VCTX210A-101)

›
For many years, it has been clear that one possible path to a cure is to transplant new beta cells and also in some way prevent the body fro...
Monday, March 21, 2022

Update On Teplizumab from Provention Bio

›
Teplizumab is a proposed treatment which, if given to someone at-risk for type-1 diabetes (T1D), can delay or possibly prevent the onset of ...
Wednesday, February 16, 2022

Verapamil Starts A Phase-II Trial (Ver-A-T1D)

›
Verapamil is a drug which has been used in the US since 1982 for high blood pressure, migraines, and heart problems.  It also lowers levels...
Wednesday, January 12, 2022

No One Was Cured Of Type-1 Diabetes in 2021

›
You might have seen a headline like one of these: Ohio man appears to be first in the world to be cured of Type 1 diabetes or this: A Cure ...
Monday, August 30, 2021

Possible Cures for Type-1 in the News (August)

›
This blog is a collection of short updates, mostly from the ADA conference. Diet (Macronutrients) Does not Impact T1D Risk Macronutrients a...
Saturday, July 17, 2021

TrialNet In General

›
I have blogged dozens of times on clinical trials run by TrialNet, but I've never discussed TrialNet as an organization, so this blog ...